Risk factors of the thyroid cancer
DOI:
https://doi.org/10.12775/QS.2025.42.60431Keywords
thyroid cancer, risk factorsAbstract
Introduction and purpose: These days, thyroid cancer (TC) is the most common endocrine cancer. According to ,,Cancer in Poland in 2022” thyroid cancer affected 47800 women in 2022. A better understanding of the illness will help develop more potent treatment and prevention strategies. The goal of our work is to classify and describe risk factors [RF] for TC.
Review Methods: A systematic search of the ‘’PubMed’’ database was conducted, focusing on studies published within the last 10 years. The search strategy used relevant key words related to TC and RF. Studies were included if they provided information on RF associated with TC in the adult population. The articles that are most relevant to the topic have been selected.
State of knowledge: It is known that TC has several RF. According to recent research, female sex, radiation, low physical activity, obesity, metabolic syndromes and lifestyle choices are the most significant RF. Other elements that raise the chance of TC include, for example family history of thyroid cancer, iodine deficiency, inadequate sleep, hormonal and genetic factors, eating meals high in sugar. Adequate physical activity, getting enough good sleep, eating dairy products, oranges and persimmons and a healthy lifestyle are associated with a lower risk of thyroid cancer; nevertheless, smoking and drinking alcohol, also reduces the disease's likelihood.
Summary: Many medical, genetic, and environmental factors are believed to be linked to a higher risk of TC. Research into RF for the disease could be useful in the development of prevention facilitating the application of suitable screening programs, diagnostic and treatment techniques. Further study is required to fully understand the etiopathology of TC, identify all RF, and verify whether they can be used for the procedure of treatment, as they are not well enough recognized.
References
1. Urszula Wojciechowska, Joanna A. Didkowska, Klaudia Barańska, Marta Miklewska, Irmina Michałek, Paweł Olasek, Agnieszka Jawołowska ,,Cancer in Poland in 2022” Maria Skłodowska-Curie National Institute of Oncology – National Research Institute; 2024.
2. Bao WQ, Zi H, Yuan QQ, Li LY, Deng T. Global burden of thyroid cancer and its attributable risk factors in 204 countries and territories from 1990 to 2019. Thorac Cancer. 2021 Sep;12(18):2494-2503. doi: 10.1111/1759-7714.14099. Epub 2021 Aug 5. PMID: 34355519; PMCID: PMC8447914.
3. Kitahara CM, Sosa JA. The changing incidence of thyroid cancer. Nat Rev Endocrinol. 2016 Nov;12(11):646-653. doi: 10.1038/nrendo.2016.110. Epub 2016 Jul 15. PMID: 27418023; PMCID: PMC10311569.
4. Bogović Crnčić T, Ilić Tomaš M, Girotto N, Grbac Ivanković S. Risk Factors for Thyroid Cancer: What Do We Know So Far? Acta Clin Croat. 2020 Jun;59(Suppl 1):66-72. doi: 10.20471/acc.2020.59.s1.08. PMID: 34219886; PMCID: PMC8212601.
5. Myung SK, Lee CW, Lee J, Kim J, Kim HS. Risk Factors for Thyroid Cancer: A Hospital-Based Case-Control Study in Korean Adults. Cancer Res Treat. 2017 Jan;49(1):70-78. doi: 10.4143/crt.2015.310. Epub 2016 Jun 23. PMID: 27338034; PMCID: PMC5266399.
6. Maleki Z, Hassanzadeh J, Ghaem H. Relationship of modifiable risk factors with the incidence of thyroid cancer: a worldwide study. BMC Res Notes. 2025 Jan 17;18(1):22. doi: 10.1186/s13104-024-07058-2. PMID: 39825428; PMCID: PMC11748574.
7. Fiore M, Cristaldi A, Okatyeva V, Lo Bianco S, Oliveri Conti G, Zuccarello P, Copat C, Caltabiano R, Cannizzaro M, Ferrante M. Physical Activity and Thyroid Cancer Risk: A Case-Control Study in Catania (South Italy). Int J Environ Res Public Health. 2019 Apr 22;16(8):1428. doi: 10.3390/ijerph16081428. PMID: 31013573; PMCID: PMC6517930.
8. Bui AQ, Gunathilake M, Lee J, Lee EK, Kim J. Relationship Between Physical Activity Levels and Thyroid Cancer Risk: A Prospective Cohort Study in Korea. Thyroid. 2022 Nov;32(11):1402-1410. doi: 10.1089/thy.2022.0250. Epub 2022 Nov 3. PMID: 36070439.
9. Feng X, Wang F, Yang W, Zheng Y, Liu C, Huang L, Li L, Cheng H, Cai H, Li X, Chen X, Yang X. Association Between Genetic Risk, Adherence to Healthy Lifestyle Behavior, and Thyroid Cancer Risk. JAMA Netw Open. 2022 Dec 1;5(12):e2246311. doi: 10.1001/jamanetworkopen.2022.46311. PMID: 36508215; PMCID: PMC9856466.
10. Karzai S, Zhang Z, Sutton W, Prescott J, Segev DL, McAdams-DeMarco M, Biswal SS, Ramanathan M Jr, Mathur A. Ambient particulate matter air pollution is associated with increased risk of papillary thyroid cancer. Surgery. 2022 Jan;171(1):212-219. doi: 10.1016/j.surg.2021.05.002. Epub 2021 Jun 29. PMID: 34210530; PMCID: PMC8688174.
11. Zeng F, Lerro C, Lavoué J, Huang H, Siemiatycki J, Zhao N, Ma S, Deziel NC, Friesen MC, Udelsman R, Zhang Y. Occupational exposure to pesticides and other biocides and risk of thyroid cancer. Occup Environ Med. 2017 Jul;74(7):502-510. doi: 10.1136/oemed-2016-103931. Epub 2017 Feb 15. PMID: 28202579; PMCID: PMC5572578.
12. Shen Y, Wang X, Wang L, Xiong D, Wu C, Cen L, Xie L, Li X. Modifiable risk factors for thyroid cancer: lifestyle and residence environment. Endokrynol Pol. 2024;75(2):119-129. doi: 10.5603/ep.97258. Epub 2024 Mar 18. PMID: 38497372.
13. Zong L, Liu G, He H, Huang D. Causal association of sleep traits with the risk of thyroid cancer: A mendelian randomization study. BMC Cancer. 2024 May 17;24(1):605. doi: 10.1186/s12885-024-12376-6. PMID: 38760772; PMCID: PMC11102272.
14. Luo J, Deziel NC, Huang H, Chen Y, Ni X, Ma S, Udelsman R, Zhang Y. Cell phone use and risk of thyroid cancer: a population-based case-control study in Connecticut. Ann Epidemiol. 2019 Jan;29:39-45. doi: 10.1016/j.annepidem.2018.10.004. Epub 2018 Oct 29. PMID: 30446214; PMCID: PMC6344271.
15. Cho A, Chang Y, Ahn J, Shin H, Ryu S. Cigarette smoking and thyroid cancer risk: a cohort study. Br J Cancer. 2018 Aug;119(5):638-645. doi: 10.1038/s41416-018-0224-5. Epub 2018 Aug 15. PMID: 30111870; PMCID: PMC6162293.
16. Lee JH, Chai YJ, Yi KH. Effect of Cigarette Smoking on Thyroid Cancer: Meta-Analysis. Endocrinol Metab (Seoul). 2021 Jun;36(3):590-598. doi: 10.3803/EnM.2021.954. Epub 2021 May 26. PMID: 34034364; PMCID: PMC8258339.
17. Hoang T, Song D, Lee J, Lee EK, Hwangbo Y, Kim J. Association among Body Mass Index, Genetic Variants of FTO, and Thyroid Cancer Risk: A Hospital-Based Case-Control Study of the Cancer Screenee Cohort in Korea. Cancer Res Treat. 2021 Jul;53(3):857-873. doi: 10.4143/crt.2020.720. Epub 2020 Dec 7. PMID: 33285050; PMCID: PMC8291195.
18. Kim J, Han K, Kim MK, Baek KH, Song KH, Kwon HS. Cumulative exposure to metabolic syndrome increases thyroid cancer risk in young adults: a population-based cohort study. Korean J Intern Med. 2023 Jul;38(4):526-533. doi: 10.3904/kjim.2022.405. Epub 2023 May 18. PMID: 37198877; PMCID: PMC10338240.
19. Kwon H, Han KD, Park CY. Weight change is significantly associated with risk of thyroid cancer: A nationwide population-based cohort study. Sci Rep. 2019 Feb 7;9(1):1546. doi: 10.1038/s41598-018-38203-0. PMID: 30733504; PMCID: PMC6367378.
20. Liu J, Feng Z, Gao R, Liu P, Meng F, Fan L, Liu L, Du Y. Analysis of risk factors for papillary thyroid carcinoma and the association with thyroid function indicators. Front Endocrinol (Lausanne). 2024 Sep 2;15:1429932. doi: 10.3389/fendo.2024.1429932. PMID: 39286267; PMCID: PMC11402740.
21. Kim J, Kim MK, Baek KH, Song KH, Han K, Kwon HS. Repeated Low High-Density Lipoprotein Cholesterol and the Risk of Thyroid Cancer: A Nationwide Population- Based Study in Korea. Endocrinol Metab (Seoul). 2022 Apr;37(2):303-311. doi: 10.3803/EnM.2021.1332. Epub 2022 Apr 6. PMID: 35381688; PMCID: PMC9081313.
22. Yin DT, He H, Yu K, Xie J, Lei M, Ma R, Li H, Wang Y, Liu Z. The association between thyroid cancer and insulin resistance, metabolic syndrome and its components: A systematic review and meta-analysis. Int J Surg. 2018 Sep;57:66-75. doi: 10.1016/j.ijsu.2018.07.013. Epub 2018 Aug 3. PMID: 30081182.
23. Sado J, Kitamura T, Sobue T, Sawada N, Iwasaki M, Sasazuki S, Yamaji T, Shimazu T, Tsugane S; JPHC Study Group. Risk of thyroid cancer in relation to height, weight, and body mass index in Japanese individuals: a population-based cohort study. Cancer Med. 2018 May;7(5):2200-2210. doi: 10.1002/cam4.1395. Epub 2018 Mar 25. PMID: 29577664; PMCID: PMC5943544.
24. Kitahara CM, McCullough ML, Franceschi S, Rinaldi S, Wolk A, Neta G, Olov Adami H, Anderson K, Andreotti G, Beane Freeman LE, Bernstein L, Buring JE, Clavel-Chapelon F, De Roo LA, Gao YT, Gaziano JM, Giles GG, Håkansson N, Horn-Ross PL, Kirsh VA, Linet MS, MacInnis RJ, Orsini N, Park Y, Patel AV, Purdue MP, Riboli E, Robien K, Rohan T, Sandler DP, Schairer C, Schneider AB, Sesso HD, Shu XO, Singh PN, van den Brandt PA, Ward E, Weiderpass E, White E, Xiang YB, Zeleniuch-Jacquotte A, Zheng W, Hartge P, Berrington de González A. Anthropometric Factors and Thyroid Cancer Risk by Histological Subtype: Pooled Analysis of 22 Prospective Studies. Thyroid. 2016 Feb;26(2):306-18. doi: 10.1089/thy.2015.0319. PMID: 26756356; PMCID: PMC4754509.
25. Nettore IC, Colao A, Macchia PE. Nutritional and Environmental Factors in Thyroid Carcinogenesis. Int J Environ Res Public Health. 2018 Aug 13;15(8):1735. doi: 10.3390/ijerph15081735. PMID: 30104523; PMCID: PMC6121258.
26. Soares AA, Nagashima YG, Alves CX, de Medeiros KS, Lopes MMGD, Brandão-Neto J. Zinc and thyroid cancer: A systematic review and meta-analysis protocol. PLoS One. 2024 Aug 26;19(8):e0307617. doi: 10.1371/journal.pone.0307617. PMID: 39186716; PMCID: PMC11346916.
27. Zamora-Ros R, Cayssials V, Clèries R, Torrents M, Byrnes G, Weiderpass E, Sandström M, Almquist M, Boutron-Ruault MC, Tjønneland A, Kyrø C, Katzke VA, Le Cornet C, Masala G, Krogh V, Iannuzzo G, Tumino R, Milani L, Skeie G, Ubago-Guisado E, Amiano P, Chirlaque MD, Ardanaz E, Janzi S, Eriksson L, Freisling H, Heath AK, Rinaldi S, Agudo A. Sweetened beverages are associated with a higher risk of differentiated thyroid cancer in the EPIC cohort: a dietary pattern approach. Eur J Nutr. 2023 Feb;62(1):105-114. doi: 10.1007/s00394-022-02953-5. Epub 2022 Jul 30. PMID: 35907037.
28. Cao LZ, Peng XD, Xie JP, Yang FH, Wen HL, Li S. The relationship between iodine intake and the risk of thyroid cancer: A meta-analysis. Medicine (Baltimore). 2017 May;96(20):e6734. doi: 10.1097/MD.0000000000006734. PMID: 28514290; PMCID: PMC5440127.
29. Ghoshouni H, Hosseini S, Ghadiri-Anari A, Azizi R, Rahmanian M, Hazar N. Investigating papillary thyroid cancer risk factors among women living at the central region of Iran: a case-control study. BMC Endocr Disord. 2025 Jan 16;25(1):12. doi: 10.1186/s12902-025-01833-3. PMID: 39819284; PMCID: PMC11737264.
30. Iglesias ML, Schmidt A, Ghuzlan AA, Lacroix L, Vathaire F, Chevillard S, Schlumberger M. Radiation exposure and thyroid cancer: a review. Arch Endocrinol Metab. 2017 Mar-Apr;61(2):180-187. doi: 10.1590/2359-3997000000257. Epub 2017 Feb 16. PMID: 28225863; PMCID: PMC10118869.
31. Cottagiri SA, King W, Rodriguez-Villamizar L, Villeneuve PJ. The risk of thyroid cancer in relation to residential proximity to nuclear power plants: a systematic review and meta-analysis. Environ Health. 2024 Nov 29;23(1):106. doi: 10.1186/s12940-024-01143-6. PMID: 39614350; PMCID: PMC11606113.
32. Yu Q, Lv X, Liu K, Ma D, Wu Y, Dai W, Jiang H. Fertility Drugs Associated with Thyroid Cancer Risk: A Systematic Review and Meta-Analysis. Biomed Res Int. 2018 May 10;2018:7191704. doi: 10.1155/2018/7191704. PMID: 29862285; PMCID: PMC5971354.
33. O'Grady TJ, Rinaldi S, Michels KA, Adami HO, Buring JE, Chen Y, Clendenen TV, D'Aloisio A, DeHart JC, Franceschi S, Freedman ND, Gierach GL, Giles GG, Lacey JV, Lee IM, Liao LM, Linet MS, McCullough ML, Patel AV, Prizment A, Robien K, Sandler DP, Stolzenberg-Solomon R, Weiderpass E, White E, Wolk A, Zheng W, Berrington de Gonzalez A, Kitahara CM. Association of hormonal and reproductive factors with differentiated thyroid cancer risk in women: a pooled prospective cohort analysis. Int J Epidemiol. 2024 Feb 1;53(1):dyad172. doi: 10.1093/ije/dyad172. PMID: 38110618; PMCID: PMC10859160.
34. Wang P, Lv L, Qi F, Qiu F. Increased risk of papillary thyroid cancer related to hormonal factors in women. Tumour Biol. 2015 Jul;36(7):5127-32. doi: 10.1007/s13277-015-3165-0. Epub 2015 Feb 11. PMID: 25669169.
35. Sun LM, Chung LM, Lin CL, Kao CH. Uterine Fibroids Increase the Risk of Thyroid Cancer. Int J Environ Res Public Health. 2020 May 28;17(11):3821. doi: 10.3390/ijerph17113821. PMID: 32481566; PMCID: PMC7312070.
36. Zabuliene L, Jasilionis D, Miseikyte-Kaubriene E, Stukas R, Kaceniene A, Smailyte G. Parity and Risk of Thyroid Cancer: a Population-Based Study in Lithuania. Horm Cancer. 2017 Dec;8(5-6):325-329. doi: 10.1007/s12672-017-0308-3. Epub 2017 Sep 15. PMID: 28916994; PMCID: PMC10355932.
37. Yi X, Zhu J, Zhu X, Liu GJ, Wu L. Breastfeeding and thyroid cancer risk in women: A dose-response meta-analysis of epidemiological studies. Clin Nutr. 2016 Oct;35(5):1039-46. doi: 10.1016/j.clnu.2015.12.005. Epub 2015 Dec 17. PMID: 26732028; PMCID: PMC4912465.
38. Wang M, Gong WW, He QF, Hu RY, Yu M. Menstrual, reproductive and hormonal factors and thyroid cancer: a hospital-based case-control study in China. BMC Womens Health. 2021 Jan 6;21(1):13. doi: 10.1186/s12905-020-01160-w. PMID: 33407401; PMCID: PMC7789638.
39. Wang F, Yan D, Ji X, Han J, Chen M, Qiao H, Zhang S. rs965513 polymorphism as a common risk marker is associated with papillary thyroid cancer. Oncotarget. 2016 Jul 5;7(27):41336-41345. doi: 10.18632/oncotarget.9324. PMID: 27191655; PMCID: PMC5173063.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Joanna Miśkiewicz, Aleksandra Ciuła, Anna Jakubiak, Łukasz Karaban, Monika Paszkowska, Michał Borawski, Klaudia Mularczyk, Patrycja Znamirowska, Tadeusz Kuźnieców, Magdalena Kupis

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 247
Number of citations: 0